GlassScriptPrepare for your visit
Alice A Sanchez
Psychiatry · Frisco, TX · NPI 1053516534
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,277.33
in general payments reported to CMS, 2019-2025 · $714 in 2025
The $714 reported for 2025 was more than what 76% of Psychiatry providers received nationally (typical 2025 total: $176).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,096.55
- Neurocrine Biosciences, INC. $631.42
- Janssen Pharmaceuticals, INC $532.27
- Corium, LLC $389.70
- Alkermes, INC. $274.71
- Brainsway USA INC $166.19
Drugs and devices associated with these payments
Vraylar Aristada Ingrezza Lybalvi Spravato Azstarys Rexulti Auvelity Dyanavel Xr Deep Tms System Quviviq Xelstrym
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Alice Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/138123/alice-a-sanchez